This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.
Beilstein J. Nanotechnol. 2019, 10, 1860–1872, doi:10.3762/bjnano.10.181
Figure 1: Characterization of PEG-SPIONs. (a) TEM images of SPIONs (left) and PEPHC1-conjugated NPs (right). ...
Figure 2: T2-weighted MR and fluorescence imaging of NPs and PNPs in vitro. (a) T2-weighted MR images of NPs ...
Figure 3: EGFRvIII expression and PEPHC1 binding with U87MG and U87MG-EGFRvIII cells. (a) Fluorescence images...
Figure 4: Cellular uptake of NPs and PNPs by U87MG and U87MG-EGFRvIII cells. (a) Fluorescence images of U87MG...
Figure 5: In vivo T2-weighted MR imaging of EGFRvIII-positive glioblastoma with PNPs. (a) T2-weighted MR imag...
Figure 6: In vivo fluorescence imaging of EGFRvIII-positive glioblastoma at different time points after PNP o...
Figure 7: Ex vivo fluorescence imaging of brain and major organs. Fluorescence imaging (a) and intensity (b) ...
Figure 8: Distribution of PNPs and NPs in brain tumor slices. (a) Fluorescence images of U87MG-EGFRvIII tumor...
Figure 9: Cytotoxicity assays of (a) NPs and (b) PNPs against U87MG and U87MG-EGFRvIII cells. The cells were ...